Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip Nutraceutical Product Line Across Canada

Published: April 17, 2019

Rapid Dose Therapeutics Corp., a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates Ltd. dated April 4, 2019 granting TFB preferred rights to distribute and sell RDT’s QuickStrip, an innovative, proprietary delivery technology for nutraceuticals to the Over The Counter Canadian retail market.

Under the terms of the Agreement, TFB will purchase, build inventory, market and distribute RDT’s line of QuickStrip™ nutraceutical products across all Canadian retail outlets, including but not limited to, chain and independent pharmacies, mass merchants, health food stores, grocery and convenience stores.

RDT’s proprietary QuickStrip technology is a Quick, Convenient, Precise, Discreet oral, fast-dissolving drug delivery system offering consumers an alternative to pills, capsules, drinks and injections. The QuickStrip nutraceutical product line delivers vitamin B12, caffeine and melatonin — penetrating the vitamin, energy and sleep consumer markets. TFB is a long-standing privately owned importer and distributor of food, beverage and health care products, bringing a wealth of knowledge, experience and success launching new brands into the retail market.

“Our strategic relationship with TFB allows RDT to launch our QuickStrip brand of nutraceutical products in retail stores across Canada — offering consumers a novel way to take their vitamins and supplements. This Agreement will provide QuickStrip brand awareness and access to targeted locations and consumers in the rapidly growing nutraceutical market,” said Mark Upsdell, CEO. “Our relationship with TFB further strengthens and positions QuickStrip for accelerated growth as an innovative global brand and delivery system to consumers with a focus on health and wellness.”

“We are very excited to work with Rapid Dose Therapeutics in launching their brand in the Canadian retail marketplace,” said Brian Riddell, Vice-president, Healthcare, TFB. “This new product brings innovation to the category with a quick and easy way to administer B12, Caffeine and Melatonin, something we haven’t seen before. With a strong consumer awareness strategy and a strategic retail launch plan in place, we look forward to bringing this product to the Canadian consumer.”